STAAB THOMAS R II Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$8,697.46
Insider Sells Quantity
46
Insider Sells Sum
$3.83M

Insider Activity of STAAB THOMAS R II

According to the SEC Form 4 filings, STAAB THOMAS R II, being in a position of

  1. Chief Financial Officer at Tenax Therapeutics, Inc.,
    оver the last 12 months, has bought 5675 shares for $10,981, and sold 0 shares,
    over all time since 2026-09-11, has bought 5675 shares for $10,981, and sold 0 shares.

Biography of STAAB THOMAS R II

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$10,9811100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-09-11PurchaseTenax Therapeutics, Inc.
TENX
Chief Financial Officer
5,675
0.0116%
$1.94$10,981-1.08%
2022-12-07PurchaseLENSAR, Inc.
LNSR
Chief Financial Officer
727
0.0069%
$3.16$2,294-7.52%
2022-12-06PurchaseLENSAR, Inc.
LNSR
Chief Financial Officer
2,025
0.0192%
$3.16$6,403-8.29%
2019-05-17SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
5,000
0.0046%
$7.45$37,250-59.62%
2019-05-16SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
14,500
0.0134%
$7.72$111,940-60.9%
2019-05-15SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
14,500
0.0131%
$7.92$114,840-62.63%
2019-05-14SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
9,000
0.0047%
$4.52$40,680-62.24%
2019-05-13SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
19,500
0.0154%
$6.63$129,383-61.1%
2019-05-09SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
19,500
0.0148%
$6.57$128,115-62.15%
2019-05-06SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
18,000
0.0156%
$7.75$139,500-63.5%
2019-05-02SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
15,500
0.012%
$6.41$99,278-60.53%
2019-04-04SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
15,000
0.011%
$7.16$107,400-66.12%
2019-01-28SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
10,000
0.0078%
$7.65$76,500-63.13%
2018-12-04SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
7,844
0.0076%
$9.45$74,126-59.39%
2018-11-23SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
7,000
0.0066%
$9.66$67,620-60.53%
2018-11-21SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
17,000
0.0136%
$8.11$137,860-59.89%
2018-11-20SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
15,746
0.0142%
$8.64$136,113-57.36%
2018-11-19SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
150
0.0001%
$6.04$906-54.57%
2018-11-08SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
24,528
0.0224%
$8.11$198,915-11%
2018-11-07SaleBioCryst Pharmaceuticals, Inc.
BCRX
Senior Vice President and CFO
1,344
0.0009%
$5.61$7,540-9.26%
Total: 49
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.